Geriatric Care Services Market size is set to exceed USD 1,490.5 billion by 2024; according to a new research study published by Global Market Insights, Inc...
Tag - neurological
The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years...